Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04264104
Other study ID # 13-CED/2019
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 28, 2020
Est. completion date October 15, 2020

Study information

Verified date February 2020
Source Aveiro University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the effects of two diferente doses of nervous system mobilization on athletes performance.


Description:

It is anticipated that 60 athletes will be randomly allocated to receive either 4x10 (n=30) or 8x10 (n=30) repetitions of neural mobilization . Data on flexibility (knee extension test) and lower limb strength and motor control (hop tests and vertical jump test) will be collected at baseline and after the neural mobilization. Statistical analysis will be performed using a mixed-methods ANOVA.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date October 15, 2020
Est. primary completion date July 28, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Healthy athletes Exclusion Criteria: - Nerve damage - Arthritis - Tumors - Vascular conditions - Spinal cord injuries - Any sistemic condition - Surgery in the past 6 months - Injury in the last 3 months - A knee angle of <10º

Study Design


Related Conditions & MeSH terms


Intervention

Other:
neural mobilization
This is a type of mobilization that uses a specific combination of joint movements

Locations

Country Name City State
Portugal basketball teams at Aveiro region Aveiro

Sponsors (1)

Lead Sponsor Collaborator
Aveiro University

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Single Leg Hop Test Participants are asked to perform one single unipedal jump and the jump width is measured. Baseline
Primary Single Leg Hop Test Participants are asked to perform one single unipedal jump and the jump width is measured. Up to 1 hour after baseline
Primary Crossover Test Participants are asked to jump as far as possible on a single leg three consecutive times, without losing balance and landing firmly. The total width of the 3 consecutive jumps is measured. Baseline
Primary Crossover Test Participants are asked to jump as far as possible on a single leg three consecutive times, without losing balance and landing firmly. The total width of the 3 consecutive jumps is measured. Up to 1 hour after baseline
Secondary 6-meter Time Hop Test The aim is to jump as fast as possible on a single leg over a distance of 6 meters, without losing balance and landing firmly. The time taken to perform this test is the measure of interest. Baseline
Secondary 6-meter Time Hop Test The aim is to jump as fast as possible on a single leg over a distance of 6 meters, without losing balance and landing firmly. The time taken to perform this test is the measure of interest. Up to 1 hour after baseline
Secondary Vertical Jump test Participants are asked to jump upwards and the height jumped is measured. Baseline
Secondary Vertical Jump test Participants are asked to jump upwards and the height jumped is measured. Up to 1 hour after baseline
Secondary Knee extension test Participants are in a prone position, hip at 90º flexion and knee extension is performed. The measure of interest is the knee extension angle. Baseline
Secondary Knee extension test Participants are in a prone position, hip at 90º flexion and knee extension is performed. The measure of interest is the knee extension angle. Up to 1 hour after baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1